Cargando…
Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients
BACKGROUND: Antibody levels against SARS-CoV-2 can be used as an indicator of recent or past vaccination or infection. However, the prognostic value of antibodies targeting the receptor binding protein (anti-RBD) in hospitalized patients is not widely reported. PURPOSE: Determine prognostic impact o...
Autores principales: | Madanat, Luai, Sager, Melinda, O’Connor, Daniel, Thapa, Bijaya, Aggarwal, Nishant, Ghimire, Bipin, Lauter, Carl, Maine, Gabriel N, Sims, Matthew, Halalau, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215841/ https://www.ncbi.nlm.nih.gov/pubmed/35755860 http://dx.doi.org/10.2147/IJGM.S370080 |
Ejemplares similares
-
Congestive Heart Failure 30-Day Readmission: Descriptive Study of Demographics, Co-morbidities, Heart Failure Knowledge, and Self-Care
por: Madanat, Luai, et al.
Publicado: (2021) -
Asystole During Nasopharyngeal Swab: Is COVID-19 to Blame?
por: Madanat, Luai, et al.
Publicado: (2021) -
Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021) -
Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022) -
Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)